Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CRON NYSE:RIV NASDAQ:TLRY NYSE:USNA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRONCronos Group$2.86$2.71$1.92▼$3.43$1.07B0.891.06 million shs1.08 million shsRIVRiverNorth Opportunities Fund$11.71+0.1%$11.59$10.93▼$12.56N/AN/A82,733 shs61,046 shsTLRYTilray Brands$4.62$5.36$4.28▼$23.20$538.46M1.893.55 million shs5.59 million shsUSNAUSANA Health Sciences$21.49-0.1%$19.04$16.60▼$38.32$396.79M0.73116,316 shs95,541 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRONCronos Group0.00%+4.76%+4.76%+13.04%+43.00%RIVRiverNorth Opportunities Fund+0.54%+2.06%+0.22%+3.68%-5.06%TLRYTilray Brands+4.29%+3.59%-14.13%-29.47%-4.78%USNAUSANA Health Sciences-1.22%+8.67%+18.80%+27.38%-33.73%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRONCronos Group$2.86$2.71$1.92▼$3.43$1.07B0.891.06 million shs1.08 million shsRIVRiverNorth Opportunities Fund$11.71+0.1%$11.59$10.93▼$12.56N/AN/A82,733 shs61,046 shsTLRYTilray Brands$4.62$5.36$4.28▼$23.20$538.46M1.893.55 million shs5.59 million shsUSNAUSANA Health Sciences$21.49-0.1%$19.04$16.60▼$38.32$396.79M0.73116,316 shs95,541 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRONCronos Group0.00%+4.76%+4.76%+13.04%+43.00%RIVRiverNorth Opportunities Fund+0.54%+2.06%+0.22%+3.68%-5.06%TLRYTilray Brands+4.29%+3.59%-14.13%-29.47%-4.78%USNAUSANA Health Sciences-1.22%+8.67%+18.80%+27.38%-33.73%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRONCronos Group 2.20Hold$2.30-19.58% DownsideRIVRiverNorth Opportunities Fund 0.00N/AN/AN/ATLRYTilray Brands 2.25Hold$11.50148.92% UpsideUSNAUSANA Health Sciences 1.50ReduceN/AN/ACurrent Analyst Ratings BreakdownLatest USNA, TLRY, CRON, and RIV Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/24/2026USNAUSANA Health Sciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)5/29/2026CRONCronos Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)5/13/2026TLRYTilray Brands Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/12/2026CRONCronos Group TD SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy4/29/2026TLRYTilray Brands Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/22/2026USNAUSANA Health Sciences Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold4/13/2026USNAUSANA Health Sciences Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy(Data available from 7/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRONCronos Group$146.59M7.28$0.01 per share228.13$3.00 per share0.95RIVRiverNorth Opportunities Fund$51.63MN/AN/AN/AN/AN/ATLRYTilray Brands$821.31M0.66$1.50 per share3.07$14.04 per share0.33USNAUSANA Health Sciences$925.94M0.43$4.09 per share5.26$29.16 per share0.74Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRONCronos Group-$9.45M$0.01286.29N/AN/A-1.14%-1.26%-1.20%8/6/2026 (Estimated)RIVRiverNorth Opportunities FundN/AN/AN/AN/AN/AN/AN/AN/AN/ATLRYTilray Brands-$2.19B-$13.65N/AN/AN/A-156.51%-3.31%-2.42%7/27/2026 (Estimated)USNAUSANA Health Sciences$10.76M$0.4745.737.760.850.96%6.21%4.50%7/28/2026 (Estimated)Latest USNA, TLRY, CRON, and RIV EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/28/2026Q2 2026USNAUSANA Health Sciences$0.43N/AN/AN/A$235.00 millionN/A7/27/2026Q4 2026TLRYTilray Brands-$0.01N/AN/AN/A$251.11 millionN/A5/11/2026Q1 2026CRONCronos Group$0.01$0.01N/A$0.04$42.20 million$45.21 million5/5/2026Q1 2026USNAUSANA Health Sciences$0.44$0.61+$0.17$0.41$240.99 million$250.22 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCRONCronos GroupN/AN/AN/AN/AN/ARIVRiverNorth Opportunities Fund$1.5513.24%N/AN/AN/ATLRYTilray BrandsN/AN/AN/AN/AN/AUSNAUSANA Health SciencesN/AN/AN/AN/AN/ALatest USNA, CRON, TLRY, and RIV DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/1/2026RIVRiverNorth Opportunities Fundmonthly$0.130613.46%10/16/202610/16/202610/30/20267/1/2026RIVRiverNorth Opportunities Fundmonthly$0.130613.46%9/15/20269/15/20269/30/20267/1/2026RIVRiverNorth Opportunities Fundmonthly$0.130613.46%8/14/20268/14/20268/31/20267/1/2026RIVRiverNorth Opportunities Fundmonthly$0.130613.46%7/15/20267/15/20267/31/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCRONCronos GroupN/A21.8720.73RIVRiverNorth Opportunities FundN/AN/AN/ATLRYTilray Brands0.192.791.66USNAUSANA Health SciencesN/A2.511.69Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRONCronos Group8.71%RIVRiverNorth Opportunities FundN/ATLRYTilray Brands9.35%USNAUSANA Health Sciences54.25%Insider OwnershipCompanyInsider OwnershipCRONCronos Group7.80%RIVRiverNorth Opportunities FundN/ATLRYTilray Brands0.84%USNAUSANA Health Sciences0.82%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCRONCronos Group450373.03 million343.94 millionOptionableRIVRiverNorth Opportunities FundN/AN/AN/ANot OptionableTLRYTilray Brands2,842116.55 million115.57 millionOptionableUSNAUSANA Health Sciences1,57018.46 million18.31 millionOptionableUSNA, CRON, TLRY, and RIV HeadlinesRecent News About These CompaniesKevin Guest: World Cup Determination Shows the Power of Grit, Preparation, PersistenceJuly 1 at 7:02 AM | prnewswire.com5 Low P/B Stocks That Investors Can Add to Their Portfolio in JulyJune 30 at 9:40 AM | zacks.comUSANA Health Sciences (NYSE:USNA) Shares Cross Above 200 Day Moving Average - Here's What HappenedJune 30 at 2:01 AM | americanbankingnews.comShould Value Investors Buy USANA Health Sciences (USNA) Stock?June 26, 2026 | zacks.com4 Value Stocks to Buy as Lower Energy Costs Strengthen Market OutlookJune 25, 2026 | zacks.comBrent Neidig Sells 5,002 Shares of USANA Health Sciences (NYSE:USNA) StockJune 19, 2026 | insidertrades.comUSANA Health Sciences: How The Restructuring Plan Makes It A Strong BuyJune 18, 2026 | seekingalpha.comUSANA Celebrates 10 Years of Making the World a Better Place During World Service WeekJune 16, 2026 | prnewswire.com5 Low Price-to-Book Stocks That Are Worth Buying in JuneJune 12, 2026 | zacks.comThese 4 Low Price-to-Cash Flow Stocks Have Winning PotentialJune 11, 2026 | zacks.comAre Investors Undervaluing USANA Health Sciences (USNA) Right Now?June 10, 2026 | zacks.comUSANA's Celavive Contouring Face & Neck Crème Named Among Canada's Top Skincare ProductsJune 8, 2026 | finance.yahoo.comUSANA Earns Dual Best of State Honors for Product Innovation and DevelopmentJune 4, 2026 | prnewswire.comUSANA Health Sciences (NYSE:USNA) Director Sells $43,928.50 in StockJune 2, 2026 | insidertrades.com1 stock under $50 with promising prospects and 2 we brush offJune 1, 2026 | msn.comKevin Guest Encourages Professionals to Prioritize Wellness During Professional Wellness MonthJune 1, 2026 | prnewswire.comUSANA Health Sciences (NYSE:USNA) CFO Sells $100,500.00 in StockMay 29, 2026 | insidertrades.comUSANA Health Sciences (NYSE:USNA) Director Gilbert Fuller Sells 1,057 SharesMay 27, 2026 | insidertrades.comShould Value Investors Buy USANA Health Sciences (USNA) Stock?May 25, 2026 | zacks.com4 Top Value Stocks to Buy Now as Wall Street Takes Fresh NoticeMay 22, 2026 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesMicron’s Sudden Plunge May Be an AI Buying ChanceBy Jeffrey Neal Johnson | June 23, 2026Apple Just Handed These 4 Memory Stocks Their Best News of the YearBy Bridget Bennett | June 28, 2026Micron’s HBM Surge Could Redefine the AI Growth StoryBy Thomas Hughes | June 25, 2026Is the Memory Rally Still Alive After the Semiconductor Sell-Off?By Jessica Mitacek | July 2, 2026Is OpenAI’s IPO Delay a Warning for AI Investors?By Nathan Reiff | June 29, 2026USNA, CRON, TLRY, and RIV Company DescriptionsCronos Group NASDAQ:CRON$2.86 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$2.88 +0.02 (+0.52%) As of 07/2/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.RiverNorth Opportunities Fund NYSE:RIV$11.71 +0.02 (+0.14%) Closing price 07/2/2026 03:57 PM EasternExtended Trading$11.70 0.00 (-0.01%) As of 07/2/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.RiverNorth Opportunities Fund, Inc. is a close ended equity mutual fund co- launched and co- managed by ALPS Advisors, Inc. and RiverNorth Capital Management, LLC. It invests in the equity markets. The fund seeks to invest in stocks of companies operating across the diversified sectors. RiverNorth Opportunities Fund, Inc. was formed on December 24, 2015 and is domiciled in the United States.Tilray Brands NASDAQ:TLRY$4.62 0.00 (0.00%) Closing price 07/2/2026 04:00 PM EasternExtended Trading$4.62 +0.00 (+0.11%) As of 07/2/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.USANA Health Sciences NYSE:USNA$21.49 -0.02 (-0.09%) Closing price 07/2/2026 03:59 PM EasternExtended Trading$21.00 -0.49 (-2.26%) As of 07/2/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst SanDisk’s Volatility May Be Telling Bulls What They Want to Hear Why the Comcast Spin-Off Won't Fix What's Actually Broken Shorting the Grid: Bloom Energy’s $25B AI Power Play AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus Why Kroger's Giant Eagle Deal Could Change Everything SMRs Spark a Chain Reaction for Nano Nuclear Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
